1,440
Participants
Start Date
June 14, 2021
Primary Completion Date
February 2, 2024
Study Completion Date
February 2, 2024
MenABCWY-2Gen low dose vaccine
MenABCWY-2Gen low dose vaccine is administered intramuscularly as 2 doses to participants in the ABCWY low dose Group in study Phase I, ABCWY low dose\_06 Group and ABCWY low dose\_02 Group in study Phase II (Formulation and Schedule-finding) and as 2 doses to participants in the ABCWY low dose\_01 Group, ABCWY low doseS\_02 Group and ABCWY low doseS\_06 Group in study Phase II (Sourcing).
MenABCWY-2Gen high dose vaccine
MenABCWY-2Gen high dose vaccine is administered intramuscularly 2 doses to participants in the ABCWY high dose Group in study Phase I, ABCWY high dose\_06 Group and ABCWY high dose\_02 Group in study Phase II (Formulation and Schedule-finding) and as 2 doses to participants in the ABCWY high dose\_01 Group, ABCWY high doseS\_02 Group and ABCWY high doseS\_06 Group in study Phase II (Sourcing).
Placebo
Placebo is administered intramuscularly as 2 doses to participants in the Placebo low dose Group, Placebo high dose Group in study Phase I and as 1 dose to participants in the ABCWY low dose\_06 Group, ABCWY low dose\_02 Group, ABCWY high dose\_06 Group, ABCWY high dose\_02 Group in study Phase II (Formulation and Schedule-finding).
MenB vaccine
MenB vaccine is administered intramuscularly as 2 doses in a 0,6-months schedule to participants in the Control Group in study Phase II (Formulation and Schedule-finding).
MenACWY vaccine
MenACWY vaccine is administered intramuscularly as 1 dose to participants in the Control Group in study Phase II (Formulation and Schedule-finding).
GSK Investigational Site, Brussels
GSK Investigational Site, Darlinghurst
GSK Investigational Site, Edegem
GSK Investigational Site, Fortitude Valley
GSK Investigational Site, Taringa
GSK Investigational Site, Tarragindi
GSK Investigational Site, Nedlands
GSK Investigational Site, Spearwood
GSK Investigational Site, Linkebeek
GSK Investigational Site, Ghent
GSK Investigational Site, Turku
GSK Investigational Site, Turku
GSK Investigational Site, Charleston
GSK Investigational Site, Miami Lakes
GSK Investigational Site, Doral
GSK Investigational Site, Istanbul
GSK Investigational Site, Nashville
GSK Investigational Site, Siemianowice Śląskie
GSK Investigational Site, Kocaeli
GSK Investigational Site, Cincinnati
GSK Investigational Site, Wroclaw
GSK Investigational Site, Springfield
GSK Investigational Site, Lincoln
GSK Investigational Site, San Antonio
GSK Investigational Site, Longmont
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Meridian
GSK Investigational Site, Nampa
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Salvador
GSK Investigational Site, São José do Rio Preto
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Helsinki
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Elblag
GSK Investigational Site, Katowice
GSK Investigational Site, Katowice
GSK Investigational Site, Krakow
GSK Investigational Site, Krakow
GSK Investigational Site, Luboń
GSK Investigational Site, Tarnów
GSK Investigational Site, Torun
GSK Investigational Site, Trzebnica
GSK Investigational Site, Warsaw
GSK Investigational Site, Warsaw
GSK Investigational Site, Warsaw
GSK Investigational Site, Borås
GSK Investigational Site, Karlskrona
GSK Investigational Site, Örebro
GSK Investigational Site, Stockholm
GSK Investigational Site, Umeå
Lead Sponsor
GlaxoSmithKline
INDUSTRY